» Articles » PMID: 32113704

The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak

Overview
Journal J Autoimmun
Date 2020 Mar 2
PMID 32113704
Citations 2082
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19. Person-to-person transmission of COVID-19 infection led to the isolation of patients that were subsequently administered a variety of treatments. Extensive measures to reduce person-to-person transmission of COVID-19 have been implemented to control the current outbreak. Special attention and efforts to protect or reduce transmission should be applied in susceptible populations including children, health care providers, and elderly people. In this review, we highlights the symptoms, epidemiology, transmission, pathogenesis, phylogenetic analysis and future directions to control the spread of this fatal disease.

Citing Articles

The effect of the pandemic on autoantibody rates in the general population.

Karabey M, Kaya H, Ceylan A, Kaba K, Ozdemir M, Feyzioglu B Arch Rheumatol. 2025; 39(4):541-548.

PMID: 40060139 PMC: 11883259. DOI: 10.46497/ArchRheumatol.2024.10330.


Recruitment of pulmonary intravascular macrophages in SARS-CoV-2 infected hamsters.

Rodrigues C, Aulakh G, Kroeker A, Kulkarni S, Lew J, Falzarano D Cell Tissue Res. 2025; .

PMID: 40014090 DOI: 10.1007/s00441-025-03958-2.


COVID-19 and Mental Distress and Well-Being Among Older People: A Gender Analysis in the First and Last Year of the Pandemic and in the Post-Pandemic Period.

Pilar Matud M Geriatrics (Basel). 2025; 10(1.

PMID: 39846575 PMC: 11755442. DOI: 10.3390/geriatrics10010005.


The Role of Ursodeoxycholic Acid Administration During the COVID-19 Pandemic: A Questionnaire Survey.

Zhou C, Jia R, Yang J, Liu T, Liu X, Yang L Can J Infect Dis Med Microbiol. 2025; 2025():4601882.

PMID: 39834529 PMC: 11745549. DOI: 10.1155/cjid/4601882.


Designing of an innovative conserved multiepitope subunit vaccine targeting SARS-CoV-2 glycoprotein and nucleoprotein through immunoinformatic.

Adelusi T, Ogunlana A, Oyewole M, Ojo T, Olaoba O, Oladipo E Sci Rep. 2025; 15(1):2563.

PMID: 39833186 PMC: 11747174. DOI: 10.1038/s41598-024-72495-9.


References
1.
Jaimes J, Millet J, Stout A, Andre N, Whittaker G . A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses. Viruses. 2020; 12(1). PMC: 7019228. DOI: 10.3390/v12010083. View

2.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

3.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

4.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

5.
Lu H . Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020; 14(1):69-71. DOI: 10.5582/bst.2020.01020. View